Sponsor pipeline

Beijing Bio-Targeting Therapeutics Technology Co., Ltd clinical trial pipeline

Get alerts when Beijing Bio-Targeting Therapeutics Technology Co., Ltd's trials change

3 active trials 0 recruiting 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

Active trials by phase

Phase 1
2
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06763965 Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive… Recurrent High-grade Glioma Enrolling by Invitation 2026-03-23
Phase 1
NCT07472790 A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of… High-grade Glioma Not Yet Recruiting 2026-07-14
NCT06215846 A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With… Solid Tumor Enrolling by Invitation 2025-11-26

Disease areas by active trials

Get alerts when Beijing Bio-Targeting Therapeutics Technology Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free